BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 22794695)

  • 1. Chapter 22: Hereditary and acquired angioedema.
    Georgy MS; Pongracic JA
    Allergy Asthma Proc; 2012; 33 Suppl 1():73-76. PubMed ID: 22794695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary and acquired angioedema.
    Patel G; Pongracic JA
    Allergy Asthma Proc; 2019 Nov; 40(6):441-445. PubMed ID: 31690390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting.
    Craig TJ; Bernstein JA; Farkas H; Bouillet L; Boccon-Gibod I
    Int Arch Allergy Immunol; 2014; 165(2):119-27. PubMed ID: 25401373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients.
    Mansi M; Zanichelli A; Coerezza A; Suffritti C; Wu MA; Vacchini R; Stieber C; Cichon S; Cicardi M
    J Intern Med; 2015 May; 277(5):585-93. PubMed ID: 25196353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
    Zeerleder S; Levi M
    Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
    Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
    Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acquired C1 esterase inhibitor deficiency via bradykinin-mediated angioedema: Four cases].
    Jacquin-Porretaz C; Castelain F; Daguindau E; Seilles E; Nardin C; Aubin F; Pelletier F
    Ann Dermatol Venereol; 2018 Oct; 145(10):598-602. PubMed ID: 29673745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.
    Zanichelli A; Azin GM; Wu MA; Suffritti C; Maggioni L; Caccia S; Perego F; Vacchini R; Cicardi M
    J Allergy Clin Immunol Pract; 2017; 5(5):1307-1313. PubMed ID: 28284781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of hereditary angioedema.
    Canonica GW; Rossi O
    Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology.
    Sinnathamby ES; Issa PP; Roberts L; Norwood H; Malone K; Vemulapalli H; Ahmadzadeh S; Cornett EM; Shekoohi S; Kaye AD
    Adv Ther; 2023 Mar; 40(3):814-827. PubMed ID: 36609679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic Nonhistaminergic Acquired Angioedema Versus Hereditary Angioedema.
    Andrási N; Veszeli N; Kőhalmi KV; Csuka D; Temesszentandrási G; Varga L; Farkas H
    J Allergy Clin Immunol Pract; 2018; 6(4):1205-1208. PubMed ID: 29715562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired Angioedema due to C1 Inhibitor Deficiency Preceding Splenic Marginal Zone Lymphoma: Further Insights from Clinical Practice.
    Ferriani MPL; Trevisan-Neto O; Costa JS; Melo JML; Moreno AS; Dias MM; Garibaldi PMM; Pereira GC; Chahud F; Traina F; Arruda LK
    Int Arch Allergy Immunol; 2020; 181(12):941-946. PubMed ID: 32894844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study.
    Triggianese P; Guarino MD; Pellicano C; Borzi M; Greco E; Modica S; De Carolis C; Perricone R
    Int Arch Allergy Immunol; 2017; 172(1):55-63. PubMed ID: 28222436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shortened Activated Partial Thromboplastin Time May Help in Diagnosing Hereditary and Acquired Angioedema.
    Bork K; Witzke G
    Int Arch Allergy Immunol; 2016; 170(2):101-7. PubMed ID: 27463190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Retrospective Analysis of Long-Term Prophylaxis with Berotralstat in Patients with Hereditary Angioedema and Acquired C1-Inhibitor Deficiency-Real-World Data.
    Johnson F; Stenzl A; Hofauer B; Heppt H; Ebert EV; Wollenberg B; Lochbaum R; Hahn J; Greve J; Trainotti S
    Clin Rev Allergy Immunol; 2023 Dec; 65(3):354-364. PubMed ID: 37914894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks.
    Hide M; Horiuchi T; Ohsawa I; Andresen I; Fukunaga A
    Allergol Int; 2021 Jan; 70(1):45-54. PubMed ID: 32919903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradykinin-mediated diseases.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():140-7. PubMed ID: 24925394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guidelines for the diagnosis and treatment of hereditary angioedema].
    Marković AS; Rozmanić V; Anić B; Aberle N; Racić G; Novak S; Sunara D; Grdinić B; Karadza-Lapić L; Radas MR; Karanović B; Kvenić B
    Lijec Vjesn; 2014; 136(5-6):117-29. PubMed ID: 25154179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic test indications and interpretations in patients with hereditary angioedema.
    Weiler CR; van Dellen RG
    Mayo Clin Proc; 2006 Jul; 81(7):958-72. PubMed ID: 16835976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.